Table 3. Biological characteristics of the study population as a whole and by blood pressure control status.
Whole group | Controlled HT | Uncontrolled HT | |||
Variable | n | (n = 298) | (n = 67) | (n = 231) | p-value |
Blood glucose, mg/dl | 237 | 115 ± 53 | 104 ± 27 | 119 ± 59 | 0.011 |
(mmol/l) | 6.38 ± 2.94 | 5.77 ± 1.50 | 6.60 ± 3.27 | ||
Lipids | 259 | ||||
TC, mg/dl | 220 ± 58 | 225 ± 60 | 219 ± 57 | 0.548 | |
(mmol/l) | 5.7 ± 1.5 | 5.83 ± 1.55 | 5.67 ± 1.48 | 0.462 | |
LDL-C, mg/dl | 135 ± 55 | 139 ± 57 | 134 ± 55 | 0.537 | |
(mmol/l) | 3.50 ± 1.42 | 3.60 ± 1.48 | 3.47 ± 1.42 | ||
HDL-C, mg/dl | 63 ± 18 | 62 ± 19 | 63 ± 18 | 0.530 | |
(mmol/l) | 1.63 ± 0.47 | 1.61 ± 0.49 | 1.63 ± 0.47 | ||
TG, mg/dl | 111 ± 51 | 118 ± 62 | 109 ± 47 | 0.261 | |
(mmol/l) | 1.25 ± 0.58 | 1.33 ± 0.70 | 1.23 ± 0.53 | ||
Creatinine, mg/dl | 255 | 1.04 ± 0.56 | 0.95 ± 0.27 | 1.07 ± 0.62 | 0.133 |
(μmol/l) | 91.94 ± 9.50 | 83.98 ± 23.87 | 94.59 ± 54.81 | ||
eGFR, ml/min/0.73 m² | 255 | 82 ± 31 | 86 ± 28 | 81 ± 32 | 0.319 |
Uric acid, mg/dl | 259 | 6.38 ± 2.50 | 6.60 ± 2.40 | 6.30 ± 2.50 | 0.488 |
Data are expressed as mean ± standard deviation (SD) or relative frequency (%).
TC, total cholesterol ; LDL-C, low-density lipoprotein cholesterol; HDL-C, highdensity lipoprotein cholesterol; TG, triglycerides; eGFR, estimated glomerular filtration rate.